Momenta Pharmaceuticals Inc (MNTA) Return on Assets ROA from the second quarter of 2020 to second quarter of 2019 and for the year 2020, Average High and Low, Fundamental Ratios from Jun 30 2020 to Jun 30 2019 - CSIMarket
CSIMarket Company Name, Ticker, Industry, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
Momenta Pharmaceuticals inc   (NASDAQ: MNTA)


Momenta Pharmaceuticals Inc 's ROA from the second quarter of 2020 to the second quarter of 2019 and 5 Year Period

Return on Assets, Quarterly Results, Trends, Rankings, Statistics


What is Momenta Pharmaceuticals Inc 's ROA in the second quarter of 2020?
Momenta Pharmaceuticals Inc recorded a cumulative net loss of $-228 million during 12 months ending in the second quarter of 2020, resulting in a negative return on assets (ROA) of -30.66%.

However, within the Healthcare sector 512 other companies had a higher return on assets. While Return on assets, overall ranking has advanced in the Jun 30 2020 quarter, so far to 4089, from total ROA ranking in the first quarter of 2020 at 4301.

What is ROA?


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Assets (Jun 30 2020)
II. Quarter		 (Mar 31 2020)
I. Quarter		 (Dec 31 2019)
IV. Quarter		 (Sep 30 2019)
III. Quarter		 (Jun 30 2019)
II. Quarter
Y / Y Total Assets Change 9.09 % 1.84 % 160.33 % 12.59 % 21.3 %
Y / Y Net Income Change - - - - -
Net Income (TTM) in million -228 -285 -290 -212 -217
Return On Assets (TTM) -30.66 % -38.89 % -39.76 % -42.21 % -44.34 %
MNTA's Total Ranking # 4089 # 4301 # 4836 # 4189 # 4265
Total Assets (TTM) in million 523 569 1,482 398 480
Seq. Total Assets Change -7.99 % -61.64 % 272.7 % -17.08 % -14.1 %
Seq. Net Income Change - - - - -

MNTA's 5 Years Annual ROA >> Back to MNTA Management Effectiveness >> Compare MNTA ROA to its Competitors


Return On Assets Company Ranking
Within: No.
Industry # 65
Sector # 513
Overall # 3948

Return On Assets Statistics
High Average Low
-4.81 %
-28.67 %
-56.48 %
(Dec 31 2016)   (Dec 31 2019)





Financial Statements
Momenta Pharmaceuticals Inc 's Assets $ 523 million MNTA's Balance sheet
Momenta Pharmaceuticals Inc 's Income $ -57 million Quarterly MNTA's Income Statement
MNTA's Income by Division See MNTA's Income by Division



Annual Return On Assets (Dec 31 2019)
FY 2019		 (Dec 31 2018)
FY 2018		 (Dec 31 2017)
FY 2017		 (Dec 31 2016)
FY 2016		 (Dec 31 2015)
FY 2015
Y / Y Total Assets Change 16.33 % 15.7 % -3.83 % 13.47 % 64.33 %
Total Assets in million 618 532 459 478 421
Y / Y Net Income Change - - - - -
Net Income in million -290 -176 -88 -21 -83
Annual Return On Assets -46.91 % -33.12 % -19.18 % -4.4 % -19.79 %

MNTA's 5 Years Annual ROA >> Back to MNTA Management Effectiveness >> Compare MNTA ROA to its Competitors



More Return On Assets Ratios
MNTA's' Return on Assets at Yahoo Finance
Biotechnology & Pharmaceuticals Industry Return On Assets Trends and Statistics
Healthcare Sector Roa Statistics
Roa Trends for overall market
MNTA's Roa Ratio versus Biotechnology & Pharmaceuticals Industry, Healthcare Sector and overall Market
Highest Ranking Return On Assets
Lowest Ranking Return On Assets
Subscribers only: Roa for MNTA's Competitors
Subscribers only: Roa for Momenta Pharmaceuticals Inc 's Suppliers
Subscribers only: Return On Assets for MNTA's Customers

You may also want to know
MNTA's Roi MNTA's Inventory Turnover Ratio MNTA's Growth Rates MNTA's Dividend Comparisons
MNTA's Profitability Ratios MNTA's Asset Turnover Ratio MNTA's Dividend Growth
MNTA's Roe MNTA's Valuation Ratios MNTA's Financial Strength Ratios MNTA's Dividend Payout Ratio



Companies with similar Return On Assets at Jun 30 2020, within Healthcare Sector ROA

Date modified: 2026-09-18T13:11:04+00:00


Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.